Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
206ATSE Growth

PRISM BioLab Co.,LTD

ＰＲＩＳＭ　ＢｉｏＬａｂ Yahoo Finance

Recent & upcoming events

Aug 14
Earnings 2:00
Q3 earnings announcement (scheduled)
Add to Google Calendar
May 14
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar
Feb 13
Earnings 1:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
2025
Dec 22
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
Nov 14
Earnings 1:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 13
Est.
Earnings 1:00 approx.
Full-year earnings
Add to Google Calendar
2027
Feb 12
Est.
Earnings 1:00 approx.
Q1 earnings
Add to Google Calendar
May 14
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar
Aug 13
Est.
Earnings 2:00 approx.
Q3 earnings
Add to Google Calendar

KPI highlights

FY25
Revenue ¥677M YoY +121.6%
Operating income ¥-774M margin -114.3%
Net income ¥-834M YoY —
EPS ¥-23 EPS is sourced from a different data provider than net income (for reference)
P/E —
ROE —

Quarterly fundamentals

Income & cash flow
Quarter FY25 Q4
Revenue —
Operating income —
Net income —
Operating CF —

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2024–2025）

事業法人 6.1%国内機関 35.6%海外機関 9.5%個人 10.8%未開示 38.1%20242025
事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

DBJキャピタル投資事業有限責任組合 15.8%DBJキャピタル投資事業有限責任組合ＷＭグロース３号投資事業有限責任組合 10%ＷＭグロース３号投資事業有限責任組合大和日台バイオベンチャー２号投資事業 9.8%大和日台バイオベンチャー２号投資事業有限責任組合ＪＰＬＬＣ　ＣＬＩＥＮＴ　ＡＳＳＥＴ 6.8%ＪＰＬＬＣ　ＣＬＩＥＮＴ　ＡＳＳＥＴＳ－ＳＫ　Ｊ(常任代理人　シティバンク、エヌ・エイ東京支店中島　喜一郎 5.1%中島　喜一郎ｓａｎｔｅｃ Ｈｏｌｄｉｎｇｓ株式会 3.4%ｓａｎｔｅｃ Ｈｏｌｄｉｎｇｓ株式会社竹原　大 3.2%竹原　大大原薬品工業株式会社 2.7%大原薬品工業株式会社竹田　英樹 2.5%竹田　英樹20242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
DBJキャピタル投資事業有限責任組合 5,829,000 15.8% Yuho (EDINET)
WMグロース3号投資事業有限責任組合 3,675,800 10.0% Yuho (EDINET)
大和日台バイオベンチャー2号投資事業有限責任組合 3,595,400 9.8% Yuho (EDINET)
JPLLC CLIENT ASSETS－SK J 2,500,000 6.8% Yuho (EDINET)
中島 喜一郎 1,872,000 5.1% Yuho (EDINET)
ｓａｎｔｅｃ Hｏｌｄｉｎｇｓ株式会社 1,250,000 3.4% Yuho (EDINET)
竹原 大 1,170,400 3.2% Yuho (EDINET)
大原薬品工業株式会社 1,000,000 2.7% Yuho (EDINET)
Nｅｗｔｏｎ Bｉｏｃａｐｉｔａｌ I SA， Pｒｉｃａｆ ｐｒｉｖｅｅ ｄｅ ｄｒｏｉｔ ｂｅｌｇｅ 985,000 2.7% Yuho (EDINET)
竹田 英樹 935,000 2.5% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

3/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✗ Positive ROA ROA -27.0%
✗ Positive operating cash flow ¥-1.52B
✗ ROA improved YoY -23.2% → -27.0%
✗ Operating CF exceeds net income (accrual quality) OCF ¥-1.52B / net income ¥-834M
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 77.4% → 87.8%
✓ Current ratio improved 4.40× → 8.21×
✗ No dilution (shares outstanding did not increase) 35,954,800 → 36,810,000
✗ Gross margin improved 52.5% → 39.8%
✓ Asset turnover improved 0.07× → 0.22×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio —
Current ratio 8.2×
Years of positive operating CF 1 of last 4 yrs
Payout ratio 0%
Latest fiscal year result Loss (net loss ¥834M)

Performance history

Last 10 years
0億円2億円3億円5億円7億円 FY22FY23FY24FY25

Income & assets

Unit: ¥100M
Item FY22FY23FY24FY25
Revenue 5.541.133.066.77
Operating income 0.67-4.97-7.82-7.74
Ordinary income ——-8.32-7.48
Net income 0.73-5.27-10.5-8.34
Total assets 17.412.145.330.9
Equity 16.711.535.027.1

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: ¥100M
Item FY22FY23FY24FY25
EPS ¥2¥-19¥-34¥-23
ROE 4.4%-45.9%——
Operating CF 0.90-5.65-0.96-15.2
Investing CF -0.08-0.40-2.38-0.66
Financing CF 1.110.0033.90.34
FCF 0.97-5.48-0.62-15.4

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data